<DOC>
	<DOCNO>NCT00162409</DOCNO>
	<brief_summary>Folic acid supplementation show previously associate enhanced formation p-HPPH phenytoin , metabolic pathway predominantly mediate activity CYP2C9 . The metabolism S warfarin , active enantiomer warfarin , also mediate predominantly activity CYP2C9 . The purpose present study examine relationship folic acid concentration warfarin pharmacokinetic well warfarin dose requirement among patient treat warfarin . In addition effect folic acid supplementation ( 5 mg/d ) 3 week warfarin pharmacokinetic warfarin dose requirement evaluate second part study .</brief_summary>
	<brief_title>Relationship Between Folic Acid Warfarin Metabolism Effect</brief_title>
	<detailed_description />
	<mesh_term>Folic Acid Deficiency</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Patients chronic warfarin therapy Refusal participate study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
</DOC>